Novaliq GmbH

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Shionogi Gets Daridorexant’s Japanese D

Astellas Pharma ’s Vyloy (zolbetuximab) is on track to secure EU-wide approval for treating gastric or gastro-esophageal junction adenocarcinoma, while Ipsen ’s Iqirvo (elafibranor) is poised to rece

Following a protracted regulatory review, the European Medicines Agency is at last due to decide whether to recommend in favor of pan-EU marketing authorization for lecanemab, Eisai / Biogen ’s disea

The US first-approver advantage over the European Union remains stark, with eight of ten novel agents first cleared by the US Food and Drug Administration, according to a Pink Sheet analysis of rece